What is the recommended medication regimen and dosing for an adult with anxiety?

Recommended Medication Regimen for Adult Anxiety

For adults with anxiety disorders, SSRIs are the first-line pharmacological treatment, with sertraline or escitalopram preferred, starting at low doses (sertraline 25-50 mg daily or escitalopram 10 mg daily) and titrating upward every 1-2 weeks as tolerated to therapeutic doses (sertraline 50-200 mg daily, escitalopram 10-20 mg daily). 1

First-Line Treatment: SSRIs

The evidence strongly supports SSRIs as initial pharmacotherapy across all major anxiety disorders (generalized anxiety, panic disorder, social anxiety, separation anxiety) 1, 2, 3, 4.

Specific SSRI Selection:

• Sertraline or escitalopram are preferred due to favorable tolerability profiles and lower drug interaction potential 5
• Paroxetine and fluoxetine show strong efficacy but paroxetine carries higher discontinuation syndrome risk and has been associated with increased suicidal thinking compared to other SSRIs 1
• Citalopram requires caution—maximum 40 mg daily due to QT prolongation risk 1

Dosing Strategy:

• Start with subtherapeutic "test" doses to minimize initial anxiety/agitation (a common early SSRI side effect) 1
• Increase in smallest available increments at 1-2 week intervals for shorter half-life SSRIs (sertraline, citalopram, escitalopram) 1
• For fluoxetine (longer half-life), extend titration intervals to 3-4 weeks 1
• Continue for 6-12 months after achieving remission 6

Common Pitfall: Avoid rapid up-titration—it's unclear that higher doses produce greater response, and they increase adverse effects 1. The logarithmic response model shows clinically significant improvement by week 6 and maximal improvement by week 12 or later 1.

Second-Line Options

If first SSRI trial fails after adequate duration (8-12 weeks including 2+ weeks at target dose):

Switch to:

• Alternative SSRI, or
• SNRI (venlafaxine 150-225 mg daily or duloxetine 60 mg daily) 7, 1, 2, 3

SNRIs show comparable efficacy to SSRIs 1, 2. Duloxetine has simpler dosing (60 mg once daily) and fewer cardiac concerns than venlafaxine, which requires blood pressure monitoring and caution in cardiac disease 7.

Third-Line Alternatives

When two adequate trials of SSRIs/SNRIs fail:

• Pregabalin/gabapentin 6, 5
• Buspirone (5 mg twice daily, titrate to maximum 20 mg three times daily)—useful for mild-moderate anxiety, takes 2-4 weeks to become effective 8, 5
• Tricyclic antidepressants (nortriptyline or desipramine 25 mg at bedtime, increase by 25 mg every 3-7 days, maximum 150 mg daily) 7, 8—obtain screening ECG for patients over 40 years, limit to <100 mg daily when possible due to cardiac toxicity risk 7

Benzodiazepines: Use With Extreme Caution

Benzodiazepines are NOT recommended for routine anxiety treatment despite their efficacy 9, 4, 5. While alprazolam, clonazepam, and diazepam show strong efficacy and lowest dropout rates 10, they carry significant risks:

• Cognitive impairment
• Abuse and dependence potential
• Should be time-limited only 9
• Only consider for:
  • Short-term bridging while awaiting SSRI/SNRI effect
  • Severe acute presentations
  • As-needed use for intermittent symptoms 4

If used: lorazepam 0.5-1 mg four times daily as needed (maximum 4 mg/24 hours; reduce to 0.25-0.5 mg in elderly, maximum 2 mg/24 hours) 11

Combination Therapy

For moderate-to-severe anxiety, combination CBT plus SSRI is superior to either treatment alone 1. The Child-Adolescent Anxiety Multimodal Study (CAMS) demonstrated that combination CBT plus sertraline improved response, remission, and global function more than monotherapy 1.

Critical Safety Monitoring

All SSRIs carry boxed warning for suicidal thinking/behavior through age 24 1. Close monitoring is essential, especially:

• First months of treatment
• Following dose adjustments
• Pooled risk: 1% with antidepressants vs 0.2% with placebo (NNH = 143) 1

Watch for behavioral activation/agitation (restlessness, insomnia, impulsiveness, disinhibition)—more common in younger patients and early in treatment 1. This supports slow titration strategy.

Discontinuation syndrome occurs with abrupt cessation, especially with paroxetine, fluvoxamine, and sertraline—taper over 10-14 days minimum 8, 1.

Treatment Algorithm Summary

1. Start: SSRI (sertraline or escitalopram preferred)
2. If inadequate response after 8-12 weeks: Switch to different SSRI or SNRI
3. If second trial fails: Consider pregabalin, buspirone, or TCA
4. Throughout: Combine with CBT when possible for optimal outcomes
5. Avoid: Benzodiazepines for long-term use, antihistamines (insufficient efficacy/safety data) 12

The evidence consistently demonstrates that while multiple medication classes show efficacy, SSRIs provide the best balance of effectiveness, tolerability, and safety for first-line treatment 2, 6, 3, 4.